Newly unveiled Oncorus has raised a $57 million Series A to back its efforts to use next-gen oncolytic viruses to treat aggressive cancers including a type of brain cancer, glioblastoma multiforme (GBM).
http://www.prnewswire.com/news-rele...57-million-series-a-financing-300300423.html9
That's a nice slab of cash!
Newly unveiled Oncorus has raised a $57 million Series A to back...
Add to My Watchlist
What is My Watchlist?